House dust mite allergens, store-operated Ca2+ channels and asthma

Anant B Parekh1

  • 1Laboratory of Signal Transduction, National Institute of Environmental Health Sciences, US National Institutes of Health, Department of Health and Human Services, Research Triangle Park, Durham, NC, USA.

The Journal of Physiology
|December 6, 2023
PubMed

Insights

House dust mite allergens trigger asthma by activating calcium release-activated calcium (CRAC) channels in lung cells. Targeting these CRAC channels shows promise as a new therapy for mite-induced asthma.

Area of Science:

  • Immunology
  • Cell Biology
  • Respiratory Medicine

Background:

  • House dust mite allergens are a primary cause of allergic asthma worldwide.
  • These allergens activate specific cellular pathways, leading to chronic lung inflammation.
  • Store-operated calcium release-activated calcium (CRAC) channels are implicated in asthma pathogenesis.

Purpose of the Study:

  • To explore the role of house dust mite allergens in asthma development.
  • To elucidate the signaling pathways involved, focusing on CRAC channels.
  • To discuss the therapeutic potential of targeting CRAC channels for asthma treatment.

Main Methods:

  • Review of scientific literature on mite allergens, asthma, and CRAC channels.
  • Analysis of cellular signaling pathways activated by allergens.
  • Discussion of in vivo experimental findings on CRAC channel inhibition.

Main Results:

  • Mite allergens activate CRAC channels in lung cells, promoting inflammation.
  • CRAC channel activation leads to the expression of pro-inflammatory mediators.
  • In vivo studies suggest CRAC channel targeting is a viable therapeutic strategy.

Conclusions:

  • CRAC channels are key mediators in mite-induced asthma.
  • Inhibiting CRAC channels represents a promising therapeutic avenue for allergic asthma.
  • Further research into CRAC channel modulation could lead to novel asthma treatments.

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
411
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
305
Allergic Reactions02:06

Allergic Reactions

Overview
27.5K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K